LSL Pharma Group Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CAD 4.16 million compared to CAD 2.02 million a year ago. Net loss was CAD 0.28 million compared to CAD 5.4 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 CAD | 0.00% | -2.04% | -1.03% |
06-18 | LSL Pharma Group Inc. acquired Virage Santé inc. | CI |
06-05 | LSL Pharma to Raise $4.5 Million Via Private Placements | MT |
1st Jan change | Capi. | |
---|---|---|
-1.03% | 38.05M | |
+55.19% | 815B | |
+47.26% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.40% | 247B | |
+3.64% | 229B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- LSL Stock
- News LSL Pharma Group Inc.
- LSL Pharma Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024